Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lyra Therapeutics, Inc. (LYRA)
:LYRA
See the Price Targets and Ratings of:
LYRA Financial Forecast
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$2
Hold
900.00%
Upside
Reiterated
11/14/24
Lyra Therapeutics: Hold Rating Due to Uncertainty in ENLIGHTEN-2 Trial Outcomes
BTIG
―
Hold
―
Reiterated
11/12/24
Analysts Offer Insights on Healthcare Companies: Lyra Therapeutics (NASDAQ: LYRA), Progyny (NASDAQ: PGNY) and Organogenesis Holdings (NASDAQ: ORGO)
Jefferies
$0.5
Hold
150.00%
Upside
Downgraded
05/07/24
Analysts Offer Insights on Healthcare Companies: Lyra Therapeutics (NASDAQ: LYRA), Bristol-Myers Squibb (NYSE: BMY) and Axsome Therapeutics (NASDAQ: AXSM)
Best Analysts Covering Lyra Therapeutics
Currently, no data available
Please return soon. This page is being updated.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LYRA Analyst Recommendation Trends
Rating
Apr 24
May 24
Aug 24
Nov 24
Jan 25
Strong Buy
6
6
3
2
0
Buy
0
0
0
0
0
Hold
0
4
6
8
5
Sell
0
1
1
1
0
Strong Sell
0
0
0
0
0
total
6
11
10
11
5
Each month's total comprises the sum of three months' worth of ratings.
LYRA Stock Forecast FAQ
What is LYRA’s average 12-month price target, according to analysts?
Based on analyst ratings, Lyra Therapeutics, Inc.’s 12-month average price target is $2.00.
What is LYRA’s upside potential, based on the analysts’ average price target?
Lyra Therapeutics, Inc. has 900.00% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LYRA a Buy, Sell or Hold?
Lyra Therapeutics, Inc. has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Lyra Therapeutics, Inc.’s price target?
The average price target for Lyra Therapeutics, Inc. is $2.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $2.00 ,the lowest forecast is $2.00. The average price target represents 900.00% Increase from the current price of $0.2.
The highest analyst price target is $2.00 ,the lowest forecast is $2.00. The average price target represents 900.00% Increase from the current price of $0.2.
What do analysts say about Lyra Therapeutics, Inc.?
Lyra Therapeutics, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of LYRA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.